Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme.
about
MiR-135a and MRP1 play pivotal roles in the selective lethality of phenethyl isothiocyanate to malignant glioma cells.Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.Overexpression of suppressor of IKBKE 1 is associated with vincristine resistance in colon cancer cells.Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells.BRCA1 expression serves a role in vincristine resistance in colon cancer cells.Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity.ABC transporters at the blood-brain barrier.Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.MEK inhibitor enhances sensitivity to chemotherapeutic drugs in multidrug resistant hepatocellular carcinoma cells.Reversal of doxorubicin-resistance by Salvia miltiorrhiza ligustrazine in the SHG44/doxorubicin glioma drug-resistant cell line.Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.Obstacles to Brain Tumor Therapy: Key ABC Transporters.Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2.Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells.Molecular and Structural Traits of Insulin Receptor Substrate 1/LC3 Nuclear Structures and Their Role in Autophagy Control and Tumor Cell Survival.Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapyFK506 Attenuates the MRP1-Mediated Chemoresistant Phenotype in Glioblastoma Stem-Like Cells
P2860
Q36050048-29B6C7EE-C635-44E7-84DB-E0DB22389D67Q37321206-04438C8D-7D17-466B-8643-212736FFCBE4Q37406277-274397BF-A950-4225-86E7-8E272C118DBEQ37725488-EB3B6168-489B-401E-9C69-B491A12AA4F7Q38697693-BC2C27FB-5FB5-41EC-9E51-B13374DC3D6FQ38731925-0DD29472-AE4C-4500-A89A-A1968C8AF502Q38783122-6D8BCCEE-E95D-467C-93BB-9897769F1201Q40568192-7D2B0947-FC6F-49A4-905C-736E17967AC4Q41612715-BD86FAD2-48DB-47A6-A3CF-816F8E8AD3C8Q44849482-0CFD196D-EA0C-4C92-98AE-7F53E9E86771Q47850878-09E89697-757D-4EF3-8765-F27F2182B3E0Q47935571-F46EF35C-6516-43D3-A190-4D35B96B124DQ47944360-B70BD150-78A3-4167-8B9B-DF86DB7B20D6Q50130110-8FC28A9B-10CF-474E-8414-B18AC891374AQ52649753-CC8232A8-C7A3-4710-95FC-8CFCA20B758AQ52684404-D28B4BAD-ED4D-4583-8AF1-BA567D9936B4Q52719561-CA3C8A9D-4960-45AA-A4B0-5ECA0215A18FQ58709993-FD7DA952-77C1-4B02-A88C-547769DC6638Q58749539-2C4706D2-3A80-4F57-AFDC-C5F4CA0A9F02
P2860
Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Inhibition of multidrug resist ...... rrent glioblastoma multiforme.
@en
Inhibition of multidrug resistance protein 1
@nl
type
label
Inhibition of multidrug resist ...... rrent glioblastoma multiforme.
@en
Inhibition of multidrug resistance protein 1
@nl
prefLabel
Inhibition of multidrug resist ...... rrent glioblastoma multiforme.
@en
Inhibition of multidrug resistance protein 1
@nl
P2093
P2860
P356
P1476
Inhibition of multidrug resist ...... urrent glioblastoma multiforme
@en
P2093
Amanda Tivnan
Caitrín O'Leary
Donat Kögel
Jann N Sarkaria
Jenny L Pokorny
Zaitun Zakaria
P2860
P356
10.3389/FNINS.2015.00218
P50
P577
2015-06-16T00:00:00Z